MedTrace Logo

Tranexamic Acid in Trauma Surgery Tranexamic Acid in Trauma Surgery Tranexamic Acid in Trauma Surgery

NCT04986813 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-08-03

No results posted yet for this study

Summary

This study was done to evaluate the efficacy of Tranexamic Acid (TXA) in reducing blood transfusion requirement in patients of lower limb trauma undergoing surgery.

Conditions

  • Tranexamic Acid
  • Trauma
  • Lower Extremity Fracture

Interventions

DRUG

Tranexamic acid injection

1 g of TXA in 100 ml of normal saline

OTHER

Normal Saline

100 ml

Sponsors & Collaborators

  • Jaspreet Singh

    lead OTHER

Principal Investigators

  • Gurleen Kaur, MD · Adesh Medical College & Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04986813 on ClinicalTrials.gov